News Conference News AHA 2021 No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials Todd Neale November 15, 2021
News Conference News AHA 2021 Bentracimab Rapidly, Safely Reverses Ticagrelor in Early REVERSE-IT Data Yael L. Maxwell November 15, 2021
News Conference News TCT 2021 More DAPT Duration Data, More Calls to Tailor to Individual Patients Shelley Wood November 05, 2021
News Conference News ESC 2021 OAC Analysis From MASTER DAPT Raises No Red Flags for Shorter DAPT Shelley Wood September 02, 2021
News Conference News ESC 2021 MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk Shelley Wood August 28, 2021
News Opinion Editor's Corner ESC 2021 ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress Shelley Wood August 19, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2021 Shelley Wood May 31, 2021
News Conference News ACC 2021 Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM L.A. McKeown May 16, 2021
News Daily News Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI Yael L. Maxwell April 09, 2021
News Daily News Antithrombotics for Elderly CAD Patients: One Size Doesn’t Fit All L.A. McKeown April 05, 2021
News Daily News Potent Antiplatelets Pre-CABG for ACS? Meta-analysis Stirs Debate L.A. McKeown February 26, 2021
News Daily News Site Investigators Missed Clinical Events in GLOBAL LEADERS Michael O'Riordan February 12, 2021
CME Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes